Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Qi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6729-7185; OpenAlex author ID A5022038370. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2019: 2 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 3

  1. Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancer. Co-author DOI 10.2217/imt-2021-0075↗
  2. Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages. Co-author DOI 10.1038/s41416-019-0595-2↗
  3. B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/cas.13914↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tingbo Liang · 3 shared papers, 2019–2023 · strength 0.40
  2. Xiaozhen Zhang · 2 shared papers, 2019–2023 · strength 0.30
  3. Jian Xu · 1 shared paper, 2023 · strength 0.22
  4. Enliang Li · 1 shared paper, 2023 · strength 0.22
  5. Jianxin Wang · 1 shared paper, 2019 · strength 0.10
  6. Tao Wei · 1 shared paper, 2019 · strength 0.10
  7. Qi Zhang · 1 shared paper, 2019 · strength 0.10
  8. Xueli Bai · 1 shared paper, 2019 · strength 0.10
  9. Xiaowei Dang · 1 shared paper, 2019 · strength 0.08
  10. Tao Wei · 1 shared paper, 2019 · strength 0.08
  11. Mao Ye · 1 shared paper, 2019 · strength 0.08
  12. Qi Zhang · 1 shared paper, 2019 · strength 0.08
  13. Qihan Fu · 1 shared paper, 2019 · strength 0.08
  14. Xueli Bai · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.